Update from the American College of Rheumatology: Cox-2 Inhibitors and Why We Miss Them
When Cox-2 inhibitors first came on the market there was almost euphoria: Finally, those patients with chronic pain and in need of anti-inflammatory medication have a safer alternative to the "old" anti-inflammatory drugs such as Motrin and Naprosyn-drugs which carried with them an increased risk of hospitalization and even death due... Read more








